# SUMATRIPTAN SUCCINATE

NDC: 46708-657
Generic name: sumatriptan succinate
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20251106

FDA application: ANDA213518

## Active ingredients

- SUMATRIPTAN SUCCINATE: 6 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-657"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-657
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=16b7e44d-afa0-4177-80ef-c3ae9a78a4e1